Latest News

Isis Begins Phase III Clinical Trial

August 25, 2014
Posted in ,

On August 1, Isis Pharmaceuticals, Inc. announced today the initiation of a pivotal Phase III study evaluating ISIS-SMNRx in infants with spinal muscular atrophy (SMA). The Phase III study, ENDEAR, […]

Read More ›

Cure SMA Announces New Research Funding

August 25, 2014
Posted in , ,

Cure SMA is proud to announce that we will be committing $1.8 million to new research funding over the next 12 months. Fifteen years ago, we had just one potential […]

Read More ›

Welcome to Cure SMA

August 16, 2014
Posted in

We are excited to announce that Families of SMA is now Cure SMA. In addition to this name change, we’ll also be making a number of other improvements to the […]

Read More ›
Scroll to Top